Majority of weight loss drug prescriptions going to commercially insured patients
(By Jakob Emerson for Becker’s Hospital Review ) In 2023, more than 61% of Ozempic prescriptions went to patients with
Read More
Semaglutide
Medicare spending on weight loss drugs may be lower than previously thought: Report
(By Rylee Wilson for Becker’s Hospital Review ) Medicare spending on GLP-1 medications may not be as high as some
Read MoreAn Estimated 1 in 4 Medicare Beneficiaries With Obesity or Overweight Could Be Eligible for Medicare Coverage of Wegovy, an Anti-Obesity Drug, to Reduce Heart Risk
(By Chris Lee for The Kaiser Family Foundation published April 24, 2024) In a new analysis, KFF finds that 3.6
Read More